[Effect of Krebs cycle intermediates on the blood supply and energy metabolism of ischemic myocardium].
The influence of d-ketoglutarate and succinate in acute experiments on dogs was studied by the following parameters: collateral coronary circulation (CCC) of the ischemic myocardium, systemic arterial pressure, and the content of lactic, pyruvic acids, and glucose in the blood flowing from the ischemic zone. alpha-ketoglutarate (6 mg/kg intracoronary and 60 mg/kg intravenously) proved to produce a positive effect on CCC and the contractile activity of the myocardium. Intravenous injection of alpha-ketoglutarate (12 mg/kg) and succinate (100 mg/kg) decreased significantly the consumption of glucose by the ischemic myocardium which rose after the ligation. In comparison with alpha-ketoglutarate, all doses of succinate were more effective as a factor of preventing the increase of lactic acid in the blood flowing from the ischemic zone. Thus, definite doses of alpha-ketoglutarate and succinate could be used for pharmacological correction of CCC and energy supply of the ischemic myocardium.
D000208:Acute Disease; D000818:Animals; D001794:Blood Pressure; D003097:Collateral Circulation; D003326:Coronary Circulation; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004285:Dogs; D004734:Energy Metabolism; D006339:Heart Rate; D007656:Ketoglutaric Acids / Q000627:therapeutic use*; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism*; D013386:Succinates / Q000627:therapeutic use*
D007656:Ketoglutaric Acids; D013386:Succinates
Vliianie intermediatov tsikla krebsa na krovosnabzhenie i énergeticheskiĭ obmen ishemizirovannogo miokarda.